Silva MO - Search Results

1

Syncope during boceprevir treatment in hepatitis C.

Ridruejo E, Silva MO, Mandó OG. Ridruejo E, et al. Among authors: silva mo. Ann Hepatol. 2013 Sep-Oct;12(5):837-8. Ann Hepatol. 2013. PMID: 24018506 Free article. No abstract available.

2

A randomised trial to compare the pharmacokinetic, pharmacodynamic, and antiviral effects of peginterferon alfa-2b and peginterferon alfa-2a in patients with chronic hepatitis C (COMPARE).

Silva M, Poo J, Wagner F, Jackson M, Cutler D, Grace M, Bordens R, Cullen C, Harvey J, Laughlin M. Silva M, et al. J Hepatol. 2006 Aug;45(2):204-13. doi: 10.1016/j.jhep.2006.03.008. Epub 2006 Apr 18. J Hepatol. 2006. PMID: 16780997 Clinical Trial.

3

Noncirrhotic portal hypertension: another cause of liver disease in HIV patients.

Mendizabal M, Craviotto S, Chen T, Silva MO, Reddy KR. Mendizabal M, et al. Among authors: silva mo. Ann Hepatol. 2009 Oct-Dec;8(4):390-5. Ann Hepatol. 2009. PMID: 20009143 Free article.

4

Thioctic acid-induced acute cholestatic hepatitis.

Ridruejo E, Castiglioni T, Silva MO. Ridruejo E, et al. Among authors: silva mo. Ann Pharmacother. 2011 Jul;45(7-8):e43. doi: 10.1345/aph.1Q035. Epub 2011 Jun 13. Ann Pharmacother. 2011. PMID: 21672886

5

Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice.

Ridruejo E, Adrover R, Silva MO. Ridruejo E, et al. Among authors: silva mo. Hepatology. 2011 Sep 2;54(3):1104-5; author reply 1105. doi: 10.1002/hep.24498. Hepatology. 2011. PMID: 21721024 No abstract available.

6

Effectiveness of entecavir in chronic hepatitis B NUC-naive patients in routine clinical practice.

Ridruejo E, Adrover R, Cocozzella D, Reggiardo MV, Estepo C, Schroder T, Paz S, Mendizábal M, Fainboim H, Mandó OG, Silva MO. Ridruejo E, et al. Among authors: silva mo. Int J Clin Pract. 2011 Aug;65(8):866-70. doi: 10.1111/j.1742-1241.2011.02719.x. Int J Clin Pract. 2011. PMID: 21762311

7

Genetic variation in interleukin-28B predicts SVR in hepatitis C genotype 1 Argentine patients treated with PEG IFN and ribavirin.

Ridruejo E, Solano A, Marciano S, Galdame O, Adrover R, Cocozzella D, Delettieres D, Martínez A, Gadano A, Mandó OG, Silva MO. Ridruejo E, et al. Among authors: silva mo. Ann Hepatol. 2011 Oct-Dec;10(4):452-7. Ann Hepatol. 2011. PMID: 21911885 Free article.

8

Entecavir in the treatment of chronic hepatitis B in kidney transplantation.

Ridruejo E, Adrover R, Mandó OG, Silva MO. Ridruejo E, et al. Among authors: silva mo. J Hepatol. 2012 Apr;56(4):997-8; author reply 999. doi: 10.1016/j.jhep.2011.09.019. Epub 2011 Nov 7. J Hepatol. 2012. PMID: 22075262 Free article. No abstract available.

9

Safety of long-term nucleos(t)ide treatment in chronic hepatitis B.

Ridruejo E, Silva MO. Ridruejo E, et al. Among authors: silva mo. Expert Opin Drug Saf. 2012 May;11(3):357-60. doi: 10.1517/14740338.2012.672972. Epub 2012 Mar 15. Expert Opin Drug Saf. 2012. PMID: 22417072

10

Antiviral activity of boceprevir monotherapy in treatment-naive subjects with chronic hepatitis C genotype 2/3.

Silva MO, Treitel M, Graham DJ, Curry S, Frontera MJ, McMonagle P, Gupta S, Hughes E, Chase R, Lahser F, Barnard RJ, Howe AY, Howe JA. Silva MO, et al. J Hepatol. 2013 Jul;59(1):31-7. doi: 10.1016/j.jhep.2013.02.018. Epub 2013 Feb 27. J Hepatol. 2013. PMID: 23454058 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191 results

Search Page

Filters